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Here we investigated on the role of the calcium activated K+-channels(BKCa) on the
regulation of the neuronal viability. Recordings of the K+-channel current were performed
using patch-clamp technique in human neuroblastoma cells (SH-SY5Y) in parallel with
measurements of the cell viability in the absence or presence of the BKCa channel
blockers iberiotoxin(IbTX) and tetraethylammonium (TEA) and the BKCa channel opener
NS1619. Protein kinase C/A (PKC, PKA) activities in the cell lysate were investigated in
the presence/absence of drugs. The whole-cell K+-current showed a slope conductance
calculated at negative membrane potentials of 126.3 pS and 1.717 nS(n = 46) following
depolarization. The intercept of the I/V curve was −33mV. IbTX(10−8 – 4 × 10−7 M)
reduced the K+-current at +30mV with an IC50 of 1.85 10−7 M and an Imax of 46%
(slope = 2.198) (n = 21). NS1619(10–100 × 10−6
× −
M) enhanced the K+-current of +141%
(n = 6), at −10mV(Vm). TEA(10−5–10−3 M) reduced the K+-current with an IC50 of 3.54 ×
10−5 M and an Imax of −90% (slope = 0.95) (n = 5). A concentration-dependent increase
of cell proliferation was observed with TEA showing a maximal proliferative effect(MPE)
of +38% (10−4 M). IbTX showed an MPE of +42% at 10−8 M concentration, reducing it
at higher concentrations. The MPE of the NS1619(100 × 10−6 M) was +42%. The PKC
inhibitor staurosporine (0.2–2
9
× 10−6 M) antagonized the proliferative actions of IbTX and
TEA. IbTX (10 × 10− M), TEA (100 × 10−6 M), and the NS1619 significantly enhanced the
PKC and PKA activities in the cell lysate with respect to the controls. These results suggest
that BKCa channel regulates proliferation of the SH-SY5Y cells through PKC and PKA
protein kinases.
Keywords: maxi-calcium activated K+-channels, cell proliferation, voltage dependent K+-channels, SH-SY5Y
neuroblastoma cells, protein kinases, staurosporine
INTRODUCTION
The calcium activated K+-channels (BKCa) channels are ubiqui-
tously present inmost human cells and play an essential role in the
regulation of basic cellular processes such as electrical excitability
of cell membrane, vascular tone, neurotransmitter release (Zhang
et al., 2003; Tricarico et al., 2005; Lee and Cui, 2010).
BKCa channels are composed by the alpha subunit encoded by
one gene (slo1/KCNMA1) assembled as tetramer and transmem-
brane beta subunits (beta1-4) encoded by KCNMB1-4 genes. The
alpha subunit of BKCa channels may assemble with beta-subunits
with 1:1 stoichiometry enhancing the calcium sensitivity, favoring
the trafficking into themembrane andmodulating the pharmaco-
logical responses (Kyle and Braun, 2014). The alpha, alpha+beta
1, alpha+beta 2/3, or beta 4 mimics the skeletal muscle, vascular
smooth muscle and neuronal BKCa channels, respectively (Orio
and Latorre, 2005; Lee and Cui, 2010). Furthermore, splicing
isoforms of the alpha subunit gene are expressed in the tis-
sues including skeletal muscle affecting physiological properties
and pharmacological response of the native channels (Dinardo
et al., 2012). More recently gamma subunits have been described
(Toro et al., 2014). The gamma subunits are auxiliary leucine-
rich repeat (LRR) -containing protein 26 (LRRC26) that fol-
lowing interaction with the BKCa channel lead to channel acti-
vation at negative voltages without rising in the intracellular
calcium concentration. Several gamma subunits have been iden-
tified in excitable and non-excitable tissues modulating the gat-
ing of a BKCa channel by enhancing the allosteric coupling
between voltage-sensor activation and the channel’s closed-open
transition (Yan and Aldrich, 2010, 2012).
Activation of BKCa channels has been reported to be involved
in the regulation of cell viability and apoptosis besides its elec-
trophysiological function. Emerging evidences suggest that the
BKCa channel plays a role in cell viability in different cell types
including osteoblasts, vascular smooth muscle cells and in cell
lines expressing the recombinant channel subunits (Henney et al.,
2009; Jia et al., 2013). It has been recently shown that high
glucose enhances HEK293 cell viability by inhibition of cloned
BKCa channel subunits hslo + beta 1 (Chang et al., 2011).
The BKCa channel openers NS1619 or tamoxifen significantly
induced apoptosis reducing cell viability in cells expressing the
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combination of the hslo + beta 1 subunits under hyperglycemia
conditions indicating that cloned BKCa channel regulates apopto-
sis and proliferation of HEK293 cell. These findings suggest that
this effect may have a role in the diabetic vascular dysfunction
associated with a vascular wall hypertrophy (Chang et al., 2011).
In line with this observation, we recently demonstrated that the
hslo subunit regulates the cell viability in response to changes
of the external K+ ion concentration (Tricarico et al., 2013).
The cell viability after 24 h of incubation under hyperkalemia
was enhanced by 82 ± 6 and 33 ± 7% in hslo-HEK293 cells
and HEK293 cells, respectively. The BKCa channel blockers iberi-
otoxin (IbTx), charybdotoxin (ChTX), and tetraethylammonium
(TEA) enhanced cell viability in hslo-HEK293 and the BKCa
openers prevented the enhancement of the cell viability induced
by hyperkalemia or IbTx in hslo-HEK293. In contrast, under
hypokalemia cell viability was reduced by −22 ± 4 and −23 ±
6% in hslo-HEK293 and HEK293 cells, respectively, thereby
suggesting that the BKCa channel regulates cell viability under
hyperkalemia but not hypokalemia conditions. These findings
may have relevance in the neuromuscular disorders associated
with abnormal K+ ion homeostasis including periodic paralysis
and myotonia. Hyperkalemia condition associated with hyper-
trophic phenotype is indeed often observed in myotonia (Adrian
and Bryant, 1974; Cannon, 1996).
The role of BKCa channels in the proliferation process in
the tumor cells is controversial. Some studies have suggested
that BKCa channels contributed to the high proliferative or
invasive potential in a number of malignant cell lines, such as
non-metastatic (MCF-7) breast cancer cells (Ouadid-Ahidouch
and Ahidouch, 2008), brain-specific metastatic (MDA-MB-361)
breast cancer cells (Khaitan et al., 2009), human prostate cancer
(Bloch et al., 2007), colorectal carcinogenesis (Koehl et al., 2010),
and glioma (Weaver et al., 2006; Sontheimer, 2008).
Some others concluded that BKCa channels are not required
for the proliferation in glioma (Abdullaev et al., 2010) or breast
cancer cells because the BKCa channel blockers charybdotoxin or
iberiotoxin did not affect cell proliferation (Roger et al., 2004).
In contrast, BKCa channels have been reported to exhibit anti-
proliferative and anti-tumorogenic properties in osteosarcoma
cells, ovarian cancer cells, glioma cells and in human MDA-MB-
231 breast cancer cells. The bisphosonates Zoledronic acid used
in the osteoporosis associated with bone metastasis and the BKCa
channel opener NS1619, induced apoptosis through the opening
of BKCa channels, while hslo gene silencing or channel blockers
induced cell proliferation (Cambien et al., 2008; Han et al., 2008;
Debska-Vielhaber et al., 2009; Ma et al., 2012).
We therefore investigated on the role of BKCa channels in the
proliferation process in SH-SY5Y neuroblastoma cells. This cell
type shows a high activity of BKCa channels, but their specific
contribution to the proliferation process is not known (Park et al.,
2010).
Moreover, very little is known about the non-conducting func-
tions of BKCa channels, in particular which signaling cascades
they modify. In this work, the ion channel characterizations were
performed using patch–clamp techniques in SH-SY5Y neuroblas-
toma cells. Cell proliferation was investigated by evaluating the
mitochondrial succinic dehydrogenases activity, cell diameter and
volume changes. The capability of the staurosporine (STS), a well-
known not selective protein kinase C inhibitor, to antagonize the
drug-induced cell proliferation was also investigated. The involve-
ment of the protein kinase C (PKC) and protein kinase A (PKA)
in the drug-induced cell proliferation was investigated using an
enzyme-linked immuno-absorbent assay (ELISA) assay in the cell
lysates.
Our findings may have relevance either in the neuromuscular
disorders where this mechanism may play a role in the cell repair
and in the proliferative disorders. PKC and PKA enzymes other
than recognized pathways involved in the cell proliferation may
have a role in the repair processes.
MATERIALS AND METHODS
DRUGS AND SOLUTIONS
In whole cell patch-clamp experiments, the pipette (intracellular)
solutions contained (10−3 M): 132 K+-glutamate, 1 ethylene gly-
col bis (β-aminoethyl ether)-N, N, N, N-tetraacetic acid (EGTA),
10 NaCl, 2 MgCl2, 10 HEPES, 1 Na2ATP, 0.3 Na2GTP, pH = 7.2
with KOH. The bath solution contained (10−3 M): 142 NaCl, 2.8
KCl, 1 CaCl2, 1 MgCl2, 11 glucose, 10 HEPES, pH = 7.4 with
NaOH. CaCl2 was added to the pipette solutions to give free Ca2+
ion concentration of 1.6 × 10−6 M in whole cell experiments. The
calculation of the free Ca2+ ion concentration in the pipette was
performed using the Maxchelator software (Stanford University,
USA).
The BKCA opener under investigation was NS1619. The selec-
tive and impermeant BKCA blocker investigated here was iberi-
otoxin (IbTX), the unselective blocker was tetraethylammonium
(TEA). The Kir blocker used was Ba2+ ions. The drugs and
toxins were purchased from Sigma (SIGMA Chemical Co., Mi,
Italy). Stock solutions of the drugs under investigation were pre-
pared dissolving the drugs in dimethylsulphoxide (DMSO) at
concentrations of 118.6 × 10−3 M. Microliter amounts of the
stock solutions were then added to the bath solutions as needed.
DMSO did not exceed 0.07% in the bath, at this concentration the
solvent does not normally affects the K+-current or cell prolif-
eration. Cell viability experiments were performed in Dulbecco’s
Modified Eagle’s Medium (DMEM) (+) solution enriched with
1X antibiotics (1%), L-glutamine (1%), and fetal serum albumin
(FBS) (10%).
PATCH-CLAMP EXPERIMENTS
The K+-currents and drug actions on the channel currents
were investigated in the human neuroblastoma cell line SH-
SY5Y during voltage steps, in the range of potentials going
from −150mV(Vm) to +110/+150mV (Vm), HP = −60mV
(Vm), in the presence of internal Ca2+ ions, in asymmetrical
K+ ion concentrations (int K+: 132 × 10−3 M; ext K+: 2.8 ×
10−3 M) using whole-cell patch-clamp technique. The resulting
K+-current was a leak subtracted and normalized to capacitance.
Drug effects were investigated in a physiological range of poten-
tials from −10mV (Vm) to + 30mV (Vm) for all drugs. The
K+-current was recorded at 20◦C and sampled at 1 kHz (filter =
2 kHz) using an Axopatch-1D amplifier equipped with a CV-4
headstage (Axon Instruments, Foster City, CA). The channel
currents were identified on the basis of their voltage dependence
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and response to toxins and drugs. The leak currents were mea-
sured in the presence of saturating concentration of Ba2+ (5 ×
10−3 M) and TEA (5 × 10−3 M) which caused a full block of Kir,
Kv, and BKCA channels.
Current analysis was performed using pClamp 10 software
package (Axon Instruments). The criteria for accepting the data
entering were based on the stability of the seal evaluated by
observing the noise levels not exceeding 0.6 pA at 2 kHz. Pipettes
resistance was 9 ± 0.2 M (Number of pipettes = 150).
The cells were exposed to the drug solutions for 2min. before
recordings. Increasing concentrations of drug solutions were
applied to the cells by the fast perfusion system (AutoMate,
Sci. Berkeley, California 94710, USA). Each application of drug
solution was followed by a washout period of 1min to allow
recovering of channel currents to control values. No more than
three different drug concentrations were applied to the same cell,
with one compound per cell tested at a time. Due to the not
reversibility of the IbTX action following washout during the time
of observation, only one concentration per cell and plate was
tested at a time for this drug. Seal resistance was continuously
monitored during patch solutions exchange.
CELL VIABILITY: MITOCHONDRIAL SUCCINIC DEHYDROGENASES
ACTIVITY ASSAY
Cell viability was evaluated by measuring the succinic dehy-
drogenases activity in the cell suspension using the cell count-
ing Kit-8 (CCK-8) (Enzo Life Sciences International, Inc.,
USA) which utilizes highly water-soluble tetrazolium salt. WST-
8 2- (2- methoxy -4-nitrophenyl) -3-(4- nitrophenyl)- 5-(2,4-
disulfophenyl)-2H- tetrazolium, monosodium salt produces a
water-soluble formazan dye upon reduction in the presence of an
electron carrier. It is reduced by mitochondrial dehydrogenases in
cells to give a yellow colored product (formazan), which is soluble
in the tissue culture medium. The detection sensitivity of CCK-8
is higher than other tetrazolium salts. The changes of the cell vital-
ity were expressed as % changes of cell viability induced by drugs
and toxin with respect to the controls.
CELL VIABILITY: CELL VOLUME ASSAY
Measures of cell volume were based on the relationship exist-
ing between voltage changes and cell volume changes. Precise
cell volumes are drawn into a sensor and the measurements are
based on the impedentiometric principle. As cells flow through
the aperture in the sensor, resistance increases. This increase in
resistance causes a subsequent increase in voltage. Voltage changes
are recorded as spikes with each passing cell and it is proportional
to the cell volume. The spikes of the same size are bucketed into
a histogram and counted. This histogram gives the quantitative
data on cell morphology that can be used to examine the qual-
ity and health of your cell culture. The Scepter™ 2.0 cell counter
(MERK-Millipore, USA) is compatible with 60 and 40μm sen-
sors, in our experiments we used the 60μm sensor for particles
between 6 and 36μm.
PROTEIN KINASE ACTIVITY ASSAY
The PKA and PKC activities assay used in our experiments are
based on a solid phase ELISA that utilizes a specific synthetic
peptide as a substrate for PKA or PKC and a polyclonal antibody
that recognizes the phosphorylated form of the substrate (Abcam,
Cambridge, UK). The assay is designed for analysis of PKA or
PKC activity in the solution phase. For statistical results, the assays
were run in triplicate. The data from the crude protein prepara-
tions were compared with the data obtained from the standard
calibration curves performed using the purified enzymes.
DATA ANALYSIS AND STATISTICS
The data were collected and analyzed using Excel software
(Microsoft Office 2010). The data are expressed as mean ± S.E.
unless otherwise specified.
In the case of the channel blockers IbTX and TEA molecules
and Ba2+ ions the data could be fitted with the following
equation:
(Idrug − Icontrol/Icontrol − Imax) × 100
= (1 + IC50/[Drug])n/Imax
I drug is the K+-current measured in the presence of the
molecules under study and normalized to the maximal currents
recorded in the same patches; IC50 is the concentrations of the
drugs needed to inhibit the current by 50%; Drug is the concen-
tration of the drug tested; I max is the maximal current recorded
in the patches at 110/150mV (Vm); I control is the current
recorded in the absence of drugs; and n is the slope factor of the
curve. The algorithms of the fitting procedures used are based on
a Marquardt least-squares fitting routine. Data analysis and plot
were performed using SigmaPlot software (Systat Software, Inc.,
San Jose, CA).
The % change of the cell viability induced by the drugs
and toxin, was calculated in respect to the controls (absence of
blockers) using the following equations:
%change of the cell viability = ([drugs]/Controls) × 100.
The Scepter™ Software Pro was used for the calculation of the cell
diameter and volume in the cell population (MERK-Millipore,
USA). Data can be exported and further analyzed using excel
software (Microsoft Office 2010).
The % activation of kinases activity (Relative PKC or PKA
activity drug/Relative PKC activity CTRL) × 100.
The % inhibition of kinases activity (Relative PKC activity
drug/Relative PKC activity CTRL) × 100 – 100.
Differences between mean were evaluated using the student t-
test, at p < 0.05 level of significance.
RESULTS
In our experiments the whole cell K+-current recorded in asym-
metrical K+ ion concentrations (int K+: 132 × 103 M; ext K+:
2.8 × 10−3 M) and internal free Ca2+ ions of 1.6 × 10−6 M con-
centration showed a sigmoid I/V relationship in the range of
membrane potentials from −150 to +70mV; a decay of the cur-
rent was observed at membrane potentials > +70mV which is
consistent with the presence of the inactivation process. The
slope conductance calculated in the range of membrane poten-
tials from −150 to −30mV was 126.3 ± 11 pS, and it was
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1.717 ± 101 nS (n = 46) in the range of membrane potentials
from −10 to +50mV (Figures 1A–C). The intercept of the I/V
curve on the voltage membrane axis was −33mV which is con-
sistent with the depolarized resting potential characterizing the
SH-SY5Y neuronal cell line (Yang and Brackenbury, 2013).
The concentration-response relationships were investigated
at −10, +10, and +30mV of voltage membrane which are phys-
iological membrane potentials for this cell line at which BKCA
channel should be operative. The application of the BKCa channel
blocker IbTX (4 × 10−7 M) induced a significant reduction of the
outward K+-current on −53% at +30mV (Vm) which was not-
reversible following washout of the toxin solution (Figure 2A).
IbTX (10−10 – 4 × 10−5 M) induced a concentration-dependent
reduction of the K+-current with an IC50 of 1.85 × 10−7 M and
an Imax of −46% (slope = 2.198) at +30mV(Vm) (n = 21)
(Figure 2B).
The application of the unselective K+ channel blocker TEA
(10−5–10−3 M) induced a concentration-dependent reduction
of the outward K+- current which was reversible following
washout of the drug solution. A full reduction of the K+-current
on −100% at +30mV (Vm) was observed in the presence
of TEA at 10−3 M concentration (Figure 2C). Concentration-
response analysis showed that TEA (10−7–10−1 M) reduced the
K+-current with an IC50 of 3.54 × 10−5 M and an Imax of −90%
(slope= 0.95) (n = 5) (Figure 2D). No significant effects of IbTX
and TEA were observed on the K+-current at negative membrane
potentials.
The BKCa channel opener NS1619(10–100 × 10−6 M)
enhanced the K+-current in the range of potentials from −10mV
to +10mV. This drug enhanced the K+-current of +41.7%
(n = 6) and +141% (n = 6) respectively at 10 × 10−6 M and
100 × 10−6 M, at −10mV(Vm), while leading to the a mild
reduction of the K+-current of −23.15% at +30mV(Vm)
suggesting a possible interaction of this drug with Kv channels
other than BKCa channels (Figure 3).
A concentration-dependent increase of the cell proliferation
was observed following 6 h of incubation time of the cells in the
presence of TEA showing a maximal proliferative effect (MPE)
of +38% at 10−4 M concentration as determined by mitochon-
drial succinic dehydrogenase activity assay. IbTX caused an MPE
of +42% at a 10−8 M concentration, but reducing its efficacy at
higher concentrations (Figure 4). This may be related to the fact
that the toxin at higher concentration per semay lead to unspecific
actions on cell viability unrelated to the BKCa channel blocking
mechanism.
The BKCa channel opener NS1619 also induced cell prolifer-
ation showing an MPE of +42% at 10−4 M concentration. The
co-incubation of the cells with NS1619+IbTx or TEA failed to
prevent the enhancement of the cell proliferation induced by
IbTX or TEA.
The co-incubation of the cells for 6 h with IbTX or TEA +
STS (0.2 × 10−6 M) fully antagonized the proliferative actions of
the IbTX and TEA (Figure 4). The STS at a 0.2 × 10−6 M con-
centration did not significantly affect the cell viability, while at a
2 × 10−6 M concentration, reduced the cell viability causing pro-
teolysis with respect to the controls according to its apoptotic
action.
The effects of the IbTX and TEA on the cell volume were
also investigated. Cell volume changes are indeed more strikingly
related to surface ion channel activity. In our experimental con-
ditions the most frequently observed cell population showed a
diameter size in the range of 13–16μm (Figure 5A). We found
FIGURE 1 | Current voltage-relationship of K+ -current recorded in
SH-SY5Y neuronal cell line. (A) A sigmoid I/V relationship of the mean K+
ions currents (n = 46) recorded in the control condition (CTRL) in
asymmetrical K+ ions concentrations (int K+: 132 × 10−3 M; ext K+:
2.8 × 10−3 M), in the presence of internal 1.6 × 10−6 M concentration of free
Ca2+ ions, in the range of potentials going from −150 to +110mV,
HP = −60mV (Vm), using whole-cell patch-clamp technique. The K+-current
was leak subtracted and normalized to capacitance. The intercept of the I/V
curve on the voltage membrane axis was −33mV. (B) Sample traces of the
K+ ions current recorded in the control conditions. (C) Sample trace of the
leak current recorded in asymmetrical K+ ion concentrations in the presence
of Ba2+ ions (5 × 10−3 M) and TEA (5 × 10−3 M) in the bath solutions.
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FIGURE 2 | Effects of the BKCa channel blockers IbTX and TEA on
K+-current recorded in SH-SY5Y neuronal cell line. The effects of IbTX and
TEA were investigated on the K+-current recorded in asymmetrical K+ ions
concentrations (int K+: 132 × 10−3 M; ext K+: 2.8 × 10−3 M), in the presence
of internal 1.6 × 10−6 M concentration of free Ca2+ ions, in the range of
potentials going from −150 to +110mV, HP = −60mV using whole cell patch
clamp technique. The whole cell K+-current was a leak subtracted and
normalized to capacitance. (A) I/V relationship in the absence or presence of
IbTX from a single patch. IbTX (4 × 10−7 M) reduced the outward K+-current
of the −53% at +30mV (Vm) in this patch. (B) IbTX (10−10–10−5 M) induced
a concentration-dependent reduction of the K+-current at +30mV (Vm). (C)
I/V relationship in the absence or presence of increasing concentrations of
unselective K+ channel blocker TEA from a single patch. (D) TEA
(10−5–10−3 M) induced a concentration-dependent reduction of the outward
K+- current. A full reduction of the K+-current on −100% at +30mV (Vm)
was observed in the presence of TEA at 10−3 M concentration.
that after 6 h of incubation time the number of cells show-
ing a diameter size in the range of 13–16μm was significantly
enhanced by IbTX and TEA (Figure 5B). IbTX (4 × 10−7 M)
equally enhanced the number of cells showing a diameter size in
the range of 6–36μm suggesting that the observed proliferation is
mostly due to an increased number of cells with normal morphol-
ogy (Figure 5B). IbTX at 4 × 10−7 M concentration induced at
comparable values of cell proliferation of +22 and +18% (diam.
range: 13–16μm) as determined by the mitochondrial succinic
dehydrogenase and the cell volume assays, respectively, suggesting
that the proliferative effect of this drug is mediated by a common
mechanism affecting either cell volume and the mitochondrial
succinic dehydrogenase enzyme. TEA instead caused a significant
enhancement of the number of cells showing a diameter size in
the range of 6–36μm in respect to that of the control cells (diam.
range: 13–16μm). This suggests the presence of an abnormal cell
population following TEA treatment with a diameter size differ-
ent from control cells. Moreover, TEA at 10−3 M concentration
induced a different quantitative enhancement of the cell prolifer-
ation of +30 and +19% (diam.: range: 6–36μm) as determined
by the mitochondrial succinic dehydrogenase and the cell volume
assays, respectively, suggesting that the two mechanisms may be
unrelated to this drug.
The basal PKC activity measured by ELISA assay after 6 h
of incubation time was higher than PKA activity in the cells
lysate in the control condition. The BKCA channel blockers
IbTX (10 × 10−9 M) and TEA (100 × 10−6 M) enhanced the PKC
activity, respectively, by 224.12 and 184.31%, with respect to the
controls; the BKCa channel opener NS1619 (50 × 10−6 M) also
enhanced PKC activity by 203.53% while as expected the STS
(0.2 × 10−6 M) reduced it by −52.12% (Figure 6A).
The BKCa channel blockers IbTX and TEA also enhanced the
PKA activity, respectively, by 241.75 and 199.96% with respect to
the controls; the BKCA channel opener NS1619 enhanced PKA
activity by 193.23%, while STS did not affect it (Figure 6B).
DISCUSSION
In the present work we investigated on the role of the BKCa
channels in the cell proliferation of the human neuroblastoma
cell line SH-SY5Y. In asymmetrical K+ ions concentrations, these
cells show an elevated K+-currents sustained by Kv and BKCa
channels, with a minor contribution of the Kirs currents to the
total K+-currents. The I/V relationship showed an S shaped form
going from −150 to +100mV (Vm) with a reduction of the
current amplitude at voltages >100mV possibly related to inac-
tivation processes characterizing Kv channels. As expected, these
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cells were depolarized as compared to the native excitable cells
such as muscle fibers or neurons (Yang and Brackenbury, 2013;
Urrego et al., 2014). In our experiments, the BKCA channels
contributed significantly to the total voltage dependent current
FIGURE 3 | Effects of the BKCa channel opener NS1619 on K+-current
recorded in SH-SY5Y neuronal cell line. The effects of the NS1619
(10 × 10−6 M and 100 × 10−6 M) were investigated on the K+-current
recorded in asymmetrical K+ ions concentrations (int K+: 132 × 10−3 M; ext
K+: 2.8 × 10−3 M), in the presence of internal 1.6 × 10−6 M concentration
of free Ca2+ ions, in the range of potentials going from −150 to +110mV,
HP = −60mV using whole cell patch clamp technique. The K+-current was
leak subtracted and normalized to capacitance. The I/V relationship was
constructed in the absence (CTRL) or presence of different concentrations
of NS1619. In the this experiment, the application of 10 × 10−6 M and
100 × 10−6 M concentrations of this drug enhanced the K+-channel current,
at −10mV (Vm), respectively by +41.7 and +171% with respect to the
control.
component; indeed the IbTX sensitive BKCa channel current was
about 50% of the total currents recorded following depolariza-
tion in the presence of 1.6 × 10−6 M concentrations of internal
free Ca2+ ions.
The BKCa channel blocker IbTX and the unselective K+ chan-
nel blocker TEA induced a maximal cell proliferation of about
40%, suggesting that BKCa channel and Kv channels similarly
contribute to cell proliferation in this cell line. The toxin at a
higher concentration of 4 × 10−7 markedly reduced channel cur-
rents of −47%, enhanced cell proliferation by +25% and cell
volume of +22% of normal cells. TEA caused a full Kv chan-
nel block, enhanced cell proliferation of about +30–40% and cell
volume of 17%. These findings are in agreement with the fact
that specific BK or Kv channel blockers are expected to increase
cell volume and proliferation while specific channel openers are
expected to reduce cell volume (Lang and Hoffmann, 2013).
In our experiments a significant cell proliferation was also
observed in the presence of low concentrations of IbTX (10−7–
10−8 M) that caused a partial reduction of the K+-current of
about −10%. Currently, we can hypothesize that this effect may
be unrelated to the conduction properties of the channel but
rather may involve protein-protein interactions that lead to acti-
vation of intracellular signaling (Urrego et al., 2014). This finding
appears to be in agreement with the idea that BKCa channels
contribute to the high proliferative or invasive potential in a
number of malignant cell lines (Weaver et al., 2006; Bloch et al.,
2007; Ouadid-Ahidouch and Ahidouch, 2008; Sontheimer, 2008;
Khaitan et al., 2009; Koehl et al., 2010). MaxiK channel over-
expression has been correlated with the malignancy of human
gliomas, which has been associated with an abnormal overactive
gBKCa channel (Toro et al., 2014).
FIGURE 4 | Effects of the channel blockers IbTX and TEA and BKCa
channel opener NS1619 on the viability of SH-SY5Y cells.
Concentration-dependent increase of the cell proliferation observed with TEA
as determined by mitochondrial succinic dehydrogenase activity assay. An
inverse relationship was observed with IbTX showing a maximal proliferative
effect on 10−8 M concentration, but reducing cell proliferation at high
concentrations. The NS1619 enhanced cell proliferation showing a maximal
proliferative effect of +117%. The co-incubation of the cells with
IbTX/TEA+STS(2 × 10−6 M) fully antagonized the proliferative actions of the
IbTX and TEA, also leading to cell death in respect to the controls. ∗Data
significantly different with respect to the controls for p < 0.05 as determined
by student t-test.
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FIGURE 5 | SH-SY5Y neuronal cell distribution in the presence or
absence of the BKCa channel blockers IbTX and TEA. The effects of the
IbTX and TEA on the cell volume were investigated. The cellular distribution
followed a Gaussian type distribution (A) The most frequently observed cell
population in our experimental condition showed a diameter size in the
range of 13–16μm as determined by cell volume assay. The mean cell
diameter did not significantly differ between treatments, the values were
14.89 ± 1 in the controls (CTRL) and were 15.02 ± 2 and 14.5 ± 1,
respectively, in the cells treated with IbTX and TEA (B) After 6 h of
incubation time the number of the cells showing a diameter size in the
range of 13–16μm was significantly enhanced by IbTX and TEA. ∗Data
significantly different with respect to the controls for p < 0.05 as
determined by student t-test.
In HEK293 cells transfected with the recombinant channel
subunits, the NS1619 prevented cell proliferation induced by the
BKCa channel blockers reducing cell viability, in our experiments
NS1619 enhanced proliferation of the SH-SY5Ycells (Chang et al.,
2011; Tricarico et al., 2013). This apparent discrepancy can be
explained, taking into account the different molecular compo-
sition and properties of the recombinant vs. the native BKCa
channel subtypes functionally expressed in the cells. NS1619 may
also exert unspecific actions, for instance against L-type Ca2+
channels (Park et al., 2007).
The cell proliferation induced by the IbTX and TEA was
prevented by staurosporine suggesting that this phenomenon
is mediated by PKC or other staurosporine-sensitive protein
kinases. We tested this hypothesis investigating the PKC and PKA
activities using an ELISA assay in the lysates of cells incubated for
6 h with BKCa and Kv channel modulators. We found a marked
enhancement of the PKC activity in the cells following IbTX,
NS1619, and TEA, while staurosporine significantly reduced the
PKC activity without significantly affecting the PKA activity in the
cell lysates.
In our experiments the involvement of the surface BKCa
channel in cell proliferation was investigated by performing
FIGURE 6 | PKC and PKA activities in SH-SY5Y neuronal cell after 6 h
incubation in the presence of the channel blockers IbTX and TEA and
opener NS1619. The effects of the BKCa channel modulators on the
protein kinase C (PKC) and protein kinase A (PKA) were investigated in the
cell lysate. The cells were incubated with the drugs under investigation for
6 h and the cell lysate were analyzed using an ELISA assay for PKC and PKA
activities (A) IbTX (10 × 10−9 M), TEA (100 × 10−6 M), and NS1619
(50 × 10−6 M) significantly enhanced PKC activity, while the STS
(0.2 × 10−6 M) reduced it with respect to the controls (B) TEA, IbTX, and
NS1819 enhanced PKA activity, while STS was without effect with respect
to the controls. ∗Data significantly different with respect to the controls for
p < 0.05 as determined by student t-test.
patch-clamp experiments and cell proliferation assays in the pres-
ence of IbTX which is a specific and almost impermeable BKCa
channel blocker. The partial channel block and the proliferation
induced by IbTX at a low concentration was accompanied by the
enhancement of the number cells showing a normal morphology
without the appearance of any abnormal cell population as deter-
mined by the cell volume assay performed in our experiments.
The fact that IbTX at a 4 × 10−7 M concentration induced at
comparable values of cell proliferation of +22 and +18% (diam.
range: 13–16μm) using the mitochondrial succinic dehydroge-
nase and the cell volume assays, respectively, suggested that the
proliferative effect of this drug is mediated by a common target
affecting either cell volume and the mitochondrial succinic dehy-
drogenase enzyme. Because IbTX is a relatively impermeant toxin,
the main target of this action can be the surface BKCa channel.
But it should be stressed that the contribution of the nuclear BKCa
channels in the neuronal cell proliferation cannot be excluded (Li
et al., 2014).
In conclusion, BKCa channel plays an essential role in the pro-
liferation of the native human neuroblastoma cell line SH-SY5Y
and this effect is mediated by PKC and PKA enzymes, other pro-
tein kinases sensitive to staurosporinemay be also involved. Other
than in cell proliferation, BKCa has been involved in cell migra-
tion. It should be stressed that BKCa channels are not currently
considered an oncogene per se, but instead can modulate cell
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migration and invasion and act like a facilitator as it has been
reported in glioma cells (Lisheng et al., 2014).
The BKCa/PKC/PKA pathway may play a role in the cell repair
processes. PKC and PKA enzymes other than recognized path-
ways involved in the proliferative disorders (Parker et al., 2014),
their induction/activation was recently associated with the cell
repair processes. The PKC isoforms particularly the alpha type,
regulates physiological processes such as phagocytosis, endocyto-
sis and desmosome downregulation; exert a cytoprotecting role
against some forms of tumors (Larsen et al., 2000; Cheeseman
et al., 2006; Boyle et al., 2014; McHarg et al., 2014). These mech-
anisms promote cell plasticity function favoring cell survival. The
induction/activation of the PKA subtypes is also involved in the
cell cytoprotection in the neurite plasmalemma repair (Zuzek
et al., 2013).
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